Who’s Hired? Former Actavis Chief Bisaro Lands A New Role

Key Roles At Viatris Also Unveiled

Industry veteran Paul Bisaro has joined the board of TherapeuticsMD and Mylan has announced new Viatris appointments, while Amneal brings in a new CFO at the same time as Fresenius Kabi’s biosimilars head exits the company.

HR_Management
Paul Bisaro and Tony Mauro are among the key industry figures with new roles • Source: Shutterstock

More from Leadership

More from Generics Bulletin